Fig. 4From: Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinologySchematic presentation of the formulated multi-epitope vaccine construct. The multi-epitope vaccine constructs included (left to right) an adjuvant and CTL, HTL, and LBL epitopes, indicated in the Brown, navy, light blue, and violet rectangular boxes, respectivelyBack to article page